Manual Review Required

BRAF V600E

solid tumor basket · Monoclonal Antibody

BRAF V600E is flagged as manual review required because public trials show treatment assignment evidence in 8 contexts. FDA CDx context should be reviewed manually.

Role evidence

Usage summary

Strongest role: Treatment Assignment

Inclusion-required count: 2

Treatment-assignment count: 3

Stratification count: 0

Threshold snippets

Fragmentation view

Threshold count: 8

Common snippets: dMMR | BRAF V600E | MSI-H

Threshold label: Moderate

FDA CDx context

Mapping summary

CDx label: Fda Cdx Context Not Found

CDx maturity score: 1/5

Confidence: Low

Patent-density signal

Diagnostic appendix

Signal count: 0

Recent signals: 0

Density label: Low

Source links

Evidence paths

https://clinicaltrials.gov/study/NCT05097599 | https://clinicaltrials.gov/study/NCT04589845 | https://clinicaltrials.gov/study/NCT05722886 | https://clinicaltrials.gov/study/NCT05159245 | https://clinicaltrials.gov/study/NCT02693535 | https://clinicaltrials.gov/study/NCT03803553 | https://clinicaltrials.gov/study/NCT07347314 | https://clinicaltrials.gov/study/NCT04551521